Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. Ohwada C, et al. Among authors: shimizu h. Biol Blood Marrow Transplant. 2020 Jan;26(1):162-170. doi: 10.1016/j.bbmt.2019.09.016. Epub 2019 Sep 16. Biol Blood Marrow Transplant. 2020. PMID: 31536824 Free article. Clinical Trial.
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study.
Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S; for Kanto Study Group for Cell Therapy (KSGCT). Kako S, et al. Among authors: shimizu h. Am J Hematol. 2020 Mar;95(3):251-257. doi: 10.1002/ajh.25693. Epub 2019 Dec 19. Am J Hematol. 2020. PMID: 31804748 Free article. Clinical Trial.
Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.
Akahoshi Y, Mizuta S, Shimizu H, Uchida N, Fukuda T, Kanamori H, Onizuka M, Ozawa Y, Ohashi K, Ohta S, Eto T, Tanaka J, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Akahoshi Y, et al. Among authors: shimizu h. Biol Blood Marrow Transplant. 2018 Oct;24(10):2009-2016. doi: 10.1016/j.bbmt.2018.06.006. Epub 2018 Jun 14. Biol Blood Marrow Transplant. 2018. PMID: 29908230 Free article. Clinical Trial.
Effect of Cytomegalovirus Reactivation With or Without Acute Graft-Versus-Host Disease on the Risk of Nonrelapse Mortality.
Akahoshi Y, Kimura SI, Inamoto Y, Seo S, Muranushi H, Shimizu H, Ozawa Y, Tanaka M, Uchida N, Kanda Y, Katayama Y, Shiratori S, Ota S, Matsuoka KI, Onizuka M, Fukuda T, Atsuta Y, Murata M, Terakura S, Nakasone H. Akahoshi Y, et al. Among authors: shimizu h. Clin Infect Dis. 2021 Aug 2;73(3):e620-e628. doi: 10.1093/cid/ciaa1871. Clin Infect Dis. 2021. PMID: 33341890
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival.
Nakasone H, Kako S, Tachibana T, Tanaka M, Onizuka M, Takahashi S, Yokota A, Fujiwara SI, Sakura T, Sakaida E, Fujisawa S, Yamazaki R, Gotoh M, Hagihara M, Aotsuka N, Tsukada N, Hatta Y, Shimizu H, Usuki K, Watanabe R, Mori T, Yano S, Kanamori H, Kanda Y. Nakasone H, et al. Among authors: shimizu h. Transplant Cell Ther. 2021 Sep;27(9):800.e1-800.e8. doi: 10.1016/j.jtct.2021.06.020. Epub 2021 Jun 24. Transplant Cell Ther. 2021. PMID: 34171522 Free article.
Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission.
Konuma T, Kondo T, Masuko M, Shimizu H, Shiratori S, Fukuda T, Kato J, Sawa M, Ozawa Y, Ota S, Uchida N, Kanda Y, Kako S, Fujisawa S, Fukushima K, Ichinohe T, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: shimizu h. Bone Marrow Transplant. 2021 Nov;56(11):2779-2787. doi: 10.1038/s41409-021-01409-4. Epub 2021 Jul 16. Bone Marrow Transplant. 2021. PMID: 34272486
Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine.
Kikuchi T, Mori T, Ohwada C, Onoda M, Shimizu H, Yokoyama H, Onizuka M, Koda Y, Kato J, Takeda Y, Hino Y, Mishina T, Sakaida E, Shono K, Nagao Y, Yokota A, Matsumoto K, Morita K, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Kikuchi T, et al. Among authors: shimizu h. Int J Hematol. 2021 Jan;113(1):128-133. doi: 10.1007/s12185-020-02990-y. Epub 2020 Sep 4. Int J Hematol. 2021. PMID: 32886279
[Clinical features of tuberculosis among allogeneic hematopoietic stem cell transplantation recipients].
Adachi H, Sekiya N, Kambara Y, Atsuta Y, Otsuka Y, Konuma R, Suzaki K, Wada A, Kishida Y, Uchibori Y, Mukae J, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Adachi H, et al. Among authors: shimizu h. Rinsho Ketsueki. 2021;62(4):239-244. doi: 10.11406/rinketsu.62.239. Rinsho Ketsueki. 2021. PMID: 33967146 Japanese.
6,349 results